Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Home
Member Profile
Kevin Bennett
Personal Information
Title
Associate Professor
Expertise
Nephropathy
Institution
Washington University in St Louis
Newsletter?
Not signed up.
Data Summary
Type
Count
Grants/SubContracts
2
Progress Reports
3
Publications
3
Protocols
0
Committees
2
Grants/Applications
Progress Reports
Publications
Presentations
Protocols
Committees
MRI-based techniques to measure renal morphology in diabetic human kidneys
The broad, long-term goal of this work is to measure kidney nephron endowment in diabetic humans, in vivo. Each nephron contains a glomerulus, which functions as a high-pressure filter of blood macromolecules. Deficits in nephrons and glomeruli are correlated with renal diseases such as diabetes, obesity, and hypertension. There is currently no noninvasive technique to count the total number of functioning renal glomeruli and nephrons in vivo, and to identify areas of nephritis at an early stage. Such a technique would enable studies of diabetic complications of the kidney in humans. We propose that contrast-enhanced MRI, using MRI-detectable nanoparticles targeted to the glomerular basement membrane, can be used to accurately count the total number of glomeruli in the whole, intact kidney. This proposal is focused on establishing this technique in healthy and diabetic human donor kidneys. We further propose to develop an automated image processing package to quantify diabetic renal morphology. Once completed, the proposed work will open the possibility of real-time, in vivo glomerular counts in studies of renal and systemic diseases in humans.
Multi-scale imaging tools to map pathology and gene expression in the human kidney
The goal of this pilot and feasibility study is to develop a multi-scale framework to evaluate the human kidney, to provide an improved understanding of diabetic kidney disease. Pathologies associated with kidney disease are highly heterogeneous, with wide variability in presentation within and between subjects. This heterogeneity limits the ability of histopathology derived from biopsies due to sampling bias, despite recent significant advances in histologic analysis. In diabetic patients, even kidney biopsies are not normally performed to detect progression to diabetic kidney disease (DKD), and noninvasive imaging biomarkers are early in development. Thus, there is a lack in knowledge about 1) Early microstructural biomarkers that could predict which diabetic patients progress to DKD or end stage kidney disease and 2) How pathology relates to structure, function, and gene expression across the entire kidney. Here we bridge the gap between anatomical structure, microstructural features, and gene expression to provide a multi-scale, three-dimensional map of the whole, intact human kidney. These preliminary studies will be performed in donor kidneys from a local organ procurement organization, not accepted for transplantation. We will investigate kidneys from both healthy and diabetic kidneys to establish preliminary data to guide future work. In Aim 1 we will combine three-dimensional, multi-parametric MRI with image-guided site directed biopsy to correlate imaging features with histopathology and measure the level of intra- and inter-kidney heterogeneity present in typical tissue. We will also investigate how these parameters relate to vascular, glomerular, and pyramidal morphology. In Aim 2 we will investigate how both single-cell and bulk RNA profiles vary within and between kidneys and how these are related to gross microstructural features. We will compare parameters measured in Aims 1-2 between kidneys from the healthy and diabetic donors. Together, this work will establish the image acquisition and processing framework to evaluate the human kidney across the scales from gross anatomy to gene expression. It will also provide preliminary data to support studies to understand heterogeneous pathology and its etiology during development of DKD.
Progress Reports
Drag a column header and drop it here to group by that column
Application
Complete Date
Report
Options
Multi-scale imaging tools to map pathology and gene expression in the human kidney (Bennett, Kevin)
6/30/2022
View Progress Report Document
Multi-scale imaging tools to map pathology and gene expression in the human kidney (Bennett, Kevin)
4/20/2023
View Progress Report Document
MRI-based techniques to measure renal morphology in diabetic human kidneys (Bennett, Kevin)
View Progress Report Document
Annual Reports
No uploaded documents found.
Publication
Altmetrics
Submitted By
PubMed ID
Status
Year: 2017; Items: 1
Measuring rat kidney glomerular number and size in vivo with MRI.
Baldelomar EJ, Charlton JR, Beeman SC, Bennett KM
American journal of physiology. Renal physiology
, 2017, ajprenal00
Bennett, Kevin
29092847
Published
Year: 2014; Items: 1
Live nephron imaging by MRI.
Qian C, Yu X, Pothayee N, Dodd S, Bouraoud N, Star R, Bennett K, Koretsky A
American journal of physiology. Renal physiology
, 2014 (307), F1162 - F1168
Submitted Externally
25186296
Published
Year: 2013; Items: 1
MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease.
Charlton JR, Beeman SC, Bennett KM
Advances in chronic kidney disease
, 2013 (20), 479 - 487
Bennett, Kevin
24206600
Published
No uploaded documents found.
No protocols found.
Name
Description
Steering Committee
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
Nephropathy
The DiaComp Nephropathy Committee has the principal function of furthering the mission of the consortium with regard to diabetic kidney disease.
Curation Flag Information
Display Stats
New comment to be added:
Flag Active?
OrderID
Experiment
Species
Status
Measurements
Options
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!